Evidence map›Paper›PMID 28130878›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2018

Development of an electrospun biomimetic polyurea scaffold suitable for vascular grafting.

Krishna Madhavan, Maria G Frid, Kendall Hunter, Robin Shandas, Kurt R Stenmark, Daewon Park

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Krishna MadhavanDepartment of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, 80045.
Maria G FridCardiovascular Pulmonary Group, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, 80045.
Kendall HunterDepartment of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, 80045.
Robin ShandasDepartment of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, 80045.
Kurt R StenmarkCardiovascular Pulmonary Group, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, 80045.
Daewon ParkDepartment of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, 80045.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary ArR01HL114887 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BULL, TODD M, BUTTRICK, PETER N. · 2012 to 2016
$3.4M
NHLBI NIH HHS P01 HL014985NHLBI NIH HHS R01 HL114887
6 · The paper itself

Abstract

The optimization of biomechanical and biochemical properties of a vascular graft to render properties relevant to physiological environments is a major challenge today. These critical properties of a vascular graft not only regulate its stability and integrity, but also control invasion of cells for scaffold remodeling permitting its integration with native tissue. In this work, we have synthesized a biomimetic scaffold by electrospinning a blend of a polyurea, poly(serinol hexamethylene urea) (PSHU), and, a polyester, poly-ε-caprolactone (PCL). Mechanical properties of the scaffold were varied by varying polymer blending ratio and electrospinning flow rate. Mechanical characterization revealed that scaffolds with lower PSHU content relative to PCL content resulted in elasticity close to native mammalian arteries. We also found that increasing electrospinning flow rates also increased the elasticity of the matrix. Optimization of elasticity generated scaffolds that enabled vascular smooth muscle cells (SMCs) to adhere, grow and maintain a SMC phenotype. The 30/70 scaffold also underwent slower degradation than scaffolds with higher PSHU content, thereby, providing the best option for in vivo remodeling. Further, Gly-Arg-Gly-Asp-Ser (RGD) covalently conjugated to the polyurea backbone in 30/70 scaffold resulted in significantly increased clotting times. Reducing surface thrombogenicity by the conjugation of RGD is critical to avoiding intimal hyperplasia. Hence, biomechanical and biochemical properties of a vascular graft can be balanced by optimizing synthesis parameters and constituent components. For these reasons, the optimized RGD-conjugated 30/70 scaffold electrospun at 2.5 or 5 mL/h has great potential as a suitable material for vascular grafting applications. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 278-290, 2018.

Indexed as

Materials TestingAnimalsBiomimetic MaterialsCattleCells, CulturedMuscle, Smooth, VascularMyocytes, Smooth MusclePolymersTissue ScaffoldsPolymerspolyureadegradationelastic modulushemocompatibilityRGDSMCvascular graft

Identifiers

PMID28130878
PMCPMC6080858
OpenAlexW2581866972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.